Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children (Q73318546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

B Duval

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Boulianne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G De Serres

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Laflamme

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P De Wals

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Massé

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Trudeau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Delage

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Desjardins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1467-1472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

Overview of clinical studies with hepatitis B vaccine made by recombinant DNA

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Immunogenicity of a recombinant hepatitis B vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Clinical experience with hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Comparison of the immunogenicity of reduced doses of two recombinant dna hepatitis b vaccines in New Zealand children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Immunogenicity of two recombinant hepatitis B vaccines in older individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Immunogenicity of yeast-derived hepatitis B vaccine from two different producers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Getting Hib vaccine to those who need it

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Hepatitis B vaccines--to switch or not to switch

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900422-3

7 January 2021

10.1016/S0264-410X(99)00422-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618544%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference